PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc. (PMVP) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
pmvp · stock forecast · 4 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Buy
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$5.00
Consensus
$5.00
+358.7% upside
Low
$5.00
Median: $5 · Last Close: $1.09
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.04 | ↓ 4.49% |
1-day model range: $1.03–$1.06. Peak: $1.06 (-4.49%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -40.1% |
| 2028 | — | -52.2% |
| 2029 | — | -57.0% |
| 2030 | — | -59.1% |
| 2031 | — | -60.1% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · PMVP · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-13 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-03-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-03-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-10-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-08-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-05-17 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-05-11 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on PMV Pharmaceuticals, Inc. (PMVP) stock. Of the recent 20 rating actions, 2 were upgrades and 0 were downgrades. 4 analysts currently cover PMVP.
Analyst Recommendation Trends
PMVP analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$3M
↓ 88.0% YoY
Revenue Next Year
$3M
↑ 1.3% YoY
EPS This Year
$-1.46
EPS Next Year
$-1.12
↓ 23.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast PMVP EPS of $-1.46 for the current fiscal year, based on estimates from 2 analysts. The PMVP revenue forecast is $3M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The PMVP stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PMVP price target is $5.00 (+358.7% upside), with an analyst consensus of Buy.
The PMVP short-term stock prediction for tomorrow is $1.04 (-4.49%). The PMVP stock prediction for 2030 projects a range of $0–$0.
PMV Pharmaceuticals, Inc. trades on NASDAQ under the ticker PMVP. The PMVP stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
PMVP forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month PMVP price target is $5.00, with a high forecast of $5.00 and a low of $5.00. The median price target is shown in the chart above when available. This implies +358.7% potential upside from the current price of $1.09.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.